Original article
Postsurgical reduction of serum lipoproteins: Interleukin-6 and the acute-phase response

https://doi.org/10.1016/S0022-2143(98)90083-XGet rights and content

Abstract

In a previous retrospective study, we reported a significant reduction in serum cholesterol levels following major surgery, and speculated on the possible role of cytokines in this reduction. The purpose of this article is to report a prospective study of the association of cytokines with postoperative changes in serum lipoprotein levels. Serum samples were obtained from 11 male patients before and at intervals for up to 10 days after surgery, and were assayed for total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), cortisol, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interferon-γ (IFN-γ). LDL-C was calculated. The TC showed a 27.9% decrease, from a mean of 4.27 mmol/L to 3.08 mmol/L (p < 0.001) after surgery, reaching a nadir at 24 hours and returning to preoperative values in 7 to 10 days. A similar decrease was noted in the HDL-C and LDL-C levels. IL-6 levels increased from a mean baseline value of 6 pg/ml to a peak of 143 pg/ml at 24 hours (p < 0.0006). There was an inverse relationship between TC and IL-6 levels, with r = −0.51 for the entire curve and r = −0.90 for the cholesterol nadir with the IL-6 peak. The other cytokines did not show significant changes. We conclude that TC and its fractions decrease to a nadir and that IL-6 increases to a peak approximately 24 hours after major surgery. There is a significant inverse correlation between TC and IL-6, suggesting a possible role of IL-6 in postoperative changes in serum lipoproteins.

References (24)

  • I Kushner

    The acute phase response: from Hippocrates to cytokine biology

  • A Sturk et al.

    Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study

    J Lab Clin Med

    (1992)
  • Cited by (57)

    • Changes in serum lipid profile in the acute and convalescent Plasmodium vivax malaria: A cohort study

      2016, Acta Tropica
      Citation Excerpt :

      All of these complications have been reported in P. vivax infection albeit less frequently (Rahimi et al., 2014). The inflammatory phase of various pathological conditions such as acute infections (Luthold et al., 2007), traumas (Akgün et al., 1998), burns (Coombes et al., 1980) and myocardial ischemia (Kittl et al., 1992) involves transient and moderate changes in serum lipid concentrations. Despite the extensive evidence indicating serum lipids are altered in P. falciparum malaria (Baptista et al., 1996; Al-Omar et al., 2010; Jacob, 2014), similar information about P. vivax malaria from clinical practice is scarce (Krishna and Chandrika, 2009).

    • Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist

      2016, Seminars in Arthritis and Rheumatism
      Citation Excerpt :

      Myasoedova et al. [14] initially reported that, in the 5 years prior to diagnosis, patients with RA had significant decreases in total cholesterol (TC) and LDL-C levels over time compared with a control population, despite lower rates of statin use. These findings were consistent with studies showing lower cholesterol levels in the setting of active inflammation from other causes, including the post-surgical state, critical illness, and sepsis [15–17]. Follow-up work in the same RA cohort of over 600 patients described a “lipid paradox”, in which lower TC and LDL-C levels were not only associated with active inflammation in RA patients, but also with higher rather than lower risk of CVD [18].

    • Levels of High-Density Lipoprotein Cholesterol are Associated with Biomarkers of Inflammation in Patients with Acute Coronary Syndrome

      2015, American Journal of Cardiology
      Citation Excerpt :

      Our data showed that HDL-C levels are correlated inversely with hs-CRP levels and directly with serum albumin levels. These findings are in agreement with other results reported in patients with other conditions associated with inflammation, including critically ill patients, where it was observed that HDL-C levels have a strong inverse correlation with levels of inflammatory cytokines such as hs-CRP, interleukin-6, and tumor necrosis factor.18–20 The precise cause of reduced HDL-C levels in these inflammatory states remains unknown; it might be attributed to several inflammatory mediators known to suppress HDL-C.7 In our study population, the multivariate analysis showed that factors associated with very low levels of HDL are consistent with those reported by Roe et al.14 However, our study also highlighted that biomarkers of inflammation (albumin levels of ≤3.5 mg/dl and hs-CRP levels of ≥10 mg/L) were strong independent predictors of very low levels of HDL-C in the ACS spectrum.

    View all citing articles on Scopus
    View full text